Jingjing Liu

7.0k total citations
220 papers, 5.0k citations indexed

About

Jingjing Liu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Jingjing Liu has authored 220 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Molecular Biology, 75 papers in Immunology and 72 papers in Cancer Research. Recurrent topics in Jingjing Liu's work include Cancer-related molecular mechanisms research (36 papers), MicroRNA in disease regulation (29 papers) and RNA modifications and cancer (28 papers). Jingjing Liu is often cited by papers focused on Cancer-related molecular mechanisms research (36 papers), MicroRNA in disease regulation (29 papers) and RNA modifications and cancer (28 papers). Jingjing Liu collaborates with scholars based in China, United States and United Kingdom. Jingjing Liu's co-authors include Antoni Barrientos, Iliana C. Soto, Flavia Fontanesi, Li‐Jia Qu, Jie Wu, Teng Pan, Xiangzhu Chen, Yuanyuan Zhang, Gui Gao and Shicong Hou and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jingjing Liu

215 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingjing Liu China 36 3.1k 1.5k 1.1k 569 401 220 5.0k
Pengyuan Yang China 35 3.4k 1.1× 1.7k 1.1× 1.0k 0.9× 816 1.4× 525 1.3× 113 5.4k
Tae‐Wook Chung South Korea 31 2.6k 0.8× 1.4k 0.9× 757 0.7× 462 0.8× 431 1.1× 129 4.5k
Yanfang Liu China 33 2.5k 0.8× 1.3k 0.8× 904 0.8× 824 1.4× 475 1.2× 206 4.4k
Ping Chen China 35 2.2k 0.7× 931 0.6× 906 0.8× 828 1.5× 597 1.5× 189 4.7k
Xiaoming Sun China 33 3.1k 1.0× 769 0.5× 1.1k 0.9× 822 1.4× 445 1.1× 83 5.3k
Qiang Sun China 39 3.3k 1.0× 1.2k 0.8× 2.5k 2.2× 775 1.4× 683 1.7× 207 6.4k
Xiaoli Zhang United States 41 3.6k 1.2× 1.8k 1.1× 1.4k 1.2× 1.5k 2.6× 357 0.9× 200 7.0k
Hsueh‐Fen Juan Taiwan 40 3.2k 1.0× 1.1k 0.7× 578 0.5× 507 0.9× 200 0.5× 165 4.8k
Wei Yan China 39 3.2k 1.0× 974 0.6× 705 0.6× 736 1.3× 377 0.9× 118 4.6k
Wenling Zhang China 38 3.4k 1.1× 2.4k 1.6× 572 0.5× 884 1.6× 393 1.0× 141 5.0k

Countries citing papers authored by Jingjing Liu

Since Specialization
Citations

This map shows the geographic impact of Jingjing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Liu more than expected).

Fields of papers citing papers by Jingjing Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Liu. The network helps show where Jingjing Liu may publish in the future.

Co-authorship network of co-authors of Jingjing Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Liu. A scholar is included among the top collaborators of Jingjing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Liu. Jingjing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Yusen, Diya Wang, Jingjing Liu, et al.. (2025). BCAA exaggerated acute and chronic ischemic heart disease through promotion of NLRP3 via Sirt1. Biochemical Pharmacology. 241. 117150–117150.
2.
3.
Huang, Xiaoshan, et al.. (2025). Inhibition of the FEN1-PBX1 axis elicits cellular senescence in breast cancer via the increased intracellular reactive oxygen species levels. Journal of Translational Medicine. 23(1). 248–248. 1 indexed citations
4.
Zhang, Yalei, Ling Qian, Kai Chen, et al.. (2025). Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial. Nature Cancer. 7(1). 60–79.
5.
Huang, Qiuhong, Lichun Tang, Meiling Wen, et al.. (2024). Expression and Regulatory Ability of Long Non-Coding RNADLX6 Antisense RNA 1 in Gestational Diabetes Mellitus. SHILAP Revista de lepidopterología. 51(3).
6.
Su, Yansen, Jingjing Liu, Zhen Gao, et al.. (2024). AMPFLDAP: Adaptive Message Passing and Feature Fusion on Heterogeneous Network for LncRNA-Disease Associations Prediction. Interdisciplinary Sciences Computational Life Sciences. 16(3). 608–622. 1 indexed citations
7.
Liu, Jingjing, et al.. (2023). Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer. International Journal of Molecular Sciences. 24(18). 14402–14402. 5 indexed citations
8.
You, Menghao, Jingjing Liu, Wenhui Guo, et al.. (2023). Mettl3-m6A-Creb1 forms an intrinsic regulatory axis in maintaining iNKT cell pool and functional differentiation. Cell Reports. 42(6). 112584–112584. 9 indexed citations
9.
Wang, Chaofan, et al.. (2023). SRSF1 regulates primordial follicle formation and number determination during meiotic prophase I. BMC Biology. 21(1). 49–49. 13 indexed citations
10.
Song, Zheng, et al.. (2022). Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy. Clinical Breast Cancer. 22(5). e655–e663. 3 indexed citations
11.
Biram, Adi, Jingjing Liu, Hadas Hezroni, et al.. (2022). Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation. Immunity. 55(3). 442–458.e8. 27 indexed citations
12.
Liu, Jingjing & Ziv Shulman. (2021). Affinity-based clonal selection in Peyer’s patches. Current Opinion in Immunology. 74. 100–105. 6 indexed citations
13.
Chen, Yu, Wen Liu, Haixu Xu, et al.. (2019). Gga-miR-19b-3p Inhibits Newcastle Disease Virus Replication by Suppressing Inflammatory Response via Targeting RNF11 and ZMYND11. Frontiers in Microbiology. 10. 2006–2006. 18 indexed citations
14.
Liu, Jingjing, Peng Chen, Yanbing Liu, et al.. (2019). Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla. Breast Cancer. 26(3). 373–377. 16 indexed citations
15.
Chen, Xiangzhu, Xiaodong Ma, Hongmei Wang, et al.. (2017). A coumarin-based colorimetric and fluorescent dual probe for palladium(ii) ions that can be used in live cells. New Journal of Chemistry. 41(16). 8026–8030. 23 indexed citations
16.
Hao, Lihong, Jingjing Liu, Sheng Zhong, Hongya Gu, & Li‐Jia Qu. (2016). AtVPS41-mediated endocytic pathway is essential for pollen tube–stigma interaction in Arabidopsis. Proceedings of the National Academy of Sciences. 113(22). 6307–6312. 71 indexed citations
17.
Liu, Jingjing, Yang Zhou, Zhendong Shi, et al.. (2016). microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7. DNA and Cell Biology. 35(9). 521–529. 39 indexed citations
18.
Yang, Lifei, Yufeng Song, Xiaomin Li, et al.. (2012). HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component. Journal of Virology. 86(14). 7662–7676. 37 indexed citations
19.
Liu, Jingjing, Shuang Liang, Xiaoxi Liu, et al.. (2012). The absence of ABCD2 sensitizes mice to disruptions in lipid metabolism by dietary erucic acid. Journal of Lipid Research. 53(6). 1071–1079. 18 indexed citations
20.
Zhu, Ying, Lu Yang, Qi Zhang, et al.. (2011). MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Research. 40(10). 4615–4625. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026